Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001404644-24-000104
Filing Date
2024-11-18
Accepted
2024-11-18 17:27:10
Documents
80
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ngne-20240930.htm   iXBRL 10-Q 1634577
2 EX-10.1 ngne-2024formq310xqxex101.htm EX-10.1 84352
3 EX-31.1 ngne-2024formq310xqxex311p.htm EX-31.1 9567
4 EX-31.2 ngne-2024formq310xqxex312p.htm EX-31.2 9697
5 EX-32.1 ngne-2024formq310xqxex321.htm EX-32.1 7275
11 ngne-20240930_g1.jpg GRAPHIC 93681
12 ngne-20240930_g2.jpg GRAPHIC 97834
  Complete submission text file 0001404644-24-000104.txt   7645799

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngne-20240930.xsd EX-101.SCH 46100
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ngne-20240930_cal.xml EX-101.CAL 68140
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ngne-20240930_def.xml EX-101.DEF 196474
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngne-20240930_lab.xml EX-101.LAB 618423
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngne-20240930_pre.xml EX-101.PRE 435624
83 EXTRACTED XBRL INSTANCE DOCUMENT ngne-20240930_htm.xml XML 822667
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

EIN.: 980542593 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36327 | Film No.: 241472532
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)